Cannabis stocks, as measured by the Global Cannabis Stock Index, were quite volatile in 2024 and then in 2025 as well. While the index did rally in December, it fell for the year. The index dropped 10 ...

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of ...

Trulieve did not report any share repurchases, but the 10-K did reveal a 2025 bonus declared on 2/24 for CEO Rivers. The company has net cash, but its tangible book value is very negative and got ...

While the U.S. gets a lot of attention from cannabis investors, the industry faces many challenges in America. More than 12 years have passed since Colorado stores opened their doors to adults, ...

Curaleaf Announces Closing of $500 Million Private Placement of 11.5% Senior Secured Notes Due 2029 ...

The Public Cannabis Company Revenue & Income Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis companies. This update is our first since the midd ...

“Adding $50 million to our balance sheet at a low rate should be good for our shareholders long term,” said Founder, Chairman and Chief Executive Officer Ben Kovler. “We are fortunate to have Valley ...

CannaInsider interviewed Charles Jones, the founder and CEO of Chooze, which offers LucidMood, a set of cannabis products targeting specific moods, including contentment, enthusiasm, fascination, and ...

Robert Weakley, CEO of Altai Brands, spoke at the State of Marijuana 2015 conference in Santa Monica in late September. The parent of Altai Brands, INDUS Holding Company, has... Download the free “New ...

GB Sciences Signs Letter of Intent to Acquire NevadaPURE’s Las Vegas Operations: Gaining $16 Million in Annualized Revenues The deal positions GB Sciences as a truly vertically integrated company ...

As 2018 was nearing an end, Namaste Technologies (TSXV:N) (OTC: NXTTF) CEO Sean Dollinger unloaded shares, which he reported on December 28th, a week after making the sales. He... Download the free ...

Tilray Brands Delivers Record Q2 Fiscal 2026 Net Revenue of $218 Million, Moves to Net Cash Position and Reaffirms Full-Year Adjusted EBITDA Guidance International Medical Cannabis Revenue Increases ...